DFX Intelligence
Venture Capital Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.
Firms / T••• B•• M••••••••• L••
T••• B•• M••••••••• L••
T••• BioVentures is a full-spectrum healthcare and life sciences venture capital firm based in Southern California. We finance brilliant entrepreneurs with game-changing healthcare technologies to give patients more of life’s most valuable asset: time. Healthcare Venture Capital | Healthcare Investors | Biotech Venture Capital | Biotech Investors | Life Sciences Venture Capital
name or self-description says syndicate platform
Importance
19
moderate
Active deployment
25
moderate
Emerging
0
low
Completeness
69
high
Freshness
98
high
Research priority
9
low
Identity and regulatory footprint
- Headquarters
- Los Angeles, CAadviserinfo.sec.gov
- Office address
- 1880 CENTURY PARK E, SUITE 200, Los Angeles, CA, 90067adviserinfo.sec.gov
- Business phone
- 858-337-8900adviserinfo.sec.gov
- Website
- t•••••••••.com
- SEC adviser type
- exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
- Latest Form ADV
- Mar 31, 2026
- Private funds reported
- 4 (4 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets
- $122Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- business phone
- 858-337-8900adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
- Sectors
- healthcare, biotech, robotics
- Stages
- seed
- Geography
- not stated
- Check size
- not stated; DFX does not estimate checks from round sizes
- Self-described
- syndicate platform
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
4 reported
| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| T•• T•• S••• L• | SPV or co-invest vehicle | 2023 adv first reported | Active deployment | $1.4M Mar 18, 2024 | 3 | unknown | unknown |
| T•• K•••• 2• S••• L• | SPV or co-invest vehicle | 2022 adv first reported | Active deployment | $13.8M Mar 18, 2024 | 23 | $0 | Oct 12, 2021 |
| T••• B••••••••• S•• I• L• | SPV or co-invest vehicle | 2021 form d first sale | Mature | $13.3M Mar 18, 2024 | 12 | $4.5M | Jan 25, 2021 |
| T••• B••••••••• I• L••• | Fund | unknown | Unknown | $81.1M Mar 18, 2024 | 62 | $0 of $100M | Aug 31, 2020 |
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
15 current, 2 departed
R••• M•••••••
AssociateAssociate
B••••••• C••••••
Board or advisoryAdvisor
D••••• L• V••••••
Board or advisoryAdvisor
J•• F••••••
Board or advisoryAdvisor
J•• A••••••
Board or advisoryScientific Advisor
L•••••• S••••••••
Board or advisoryAdvisor
P•• S•••••
Board or advisoryScientific Advisor
P••• M•••••
Board or advisoryScientific Advisor
P•••• A••••
Board or advisoryScientific Advisor
R••••• N•••••
Board or advisoryAdvisor
S••••• M••••••••
Board or advisoryScientific Advisor
S••• P•••••
Board or advisoryAdvisor
T•• W•••••
General partnerGeneral Partner
D•••• A••••• W••••••
Managing partnerManaging Member · since Sep 1, 2020
T•••••• W•••••
Managing partnerManaging Member · since Oct 1, 2020
2 departed (kept with end dates)
- J•• A•••••• · Scientific Advisor · ? to Sep 16, 2026 Inference
- S••••• M•••••••• · Scientific Advisor · ? to Sep 16, 2026 Inference
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
8 dated events
- Sep 16, 2026S••••• M•••••••• (Scientific Advisor) no longer on the team page of T••• B•• M••••••••• L••Person leftPeopleInferenceS••••• M••••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 16, 2026J•• A•••••• (Scientific Advisor) no longer on the team page of T••• B•• M••••••••• L••Person leftPeopleInferenceJ•• A••••••Venture organization websites (about, team, portfolio, thesis, news pages)
- Sep 14, 2026T••• B•• M••••••••• L••: INSTITUTIONAL_VC -> SYNDICATE_PLATFORM (name or self-description says syndicate platform)Classification changedClassificationInferenceno URL
- Mar 20, 2023T•• T•• S••• L• first reported on Form ADV by T••• B•• M••••••••• L•• (Venture Capital Fund), GAV $1,325,107Fund first reported on Form ADVFundsFactT•• T•• S••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 14, 2022T••• B••••••••• S•• I• L• first reported on Form ADV by T••• B•• M••••••••• L•• (Venture Capital Fund), GAV $5,659,795Fund first reported on Form ADVFundsFactT••• B••••••••• S•• I• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Mar 14, 2022T•• K•••• 2• S••• L• first reported on Form ADV by T••• B•• M••••••••• L•• (Venture Capital Fund), GAV $8,424,419Fund first reported on Form ADVFundsFactT•• K•••• 2• S••• L•SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Oct 29, 2020T••• B•• M••••••••• L•• first filed Form ADV (ERA, venture capital fund adviser exemption)First SEC adviser filingOrganizationFactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
- Oct 29, 2020T••• B••••••••• I• L••• first reported on Form ADV by T••• B•• M••••••••• L•• (Venture Capital Fund), GAV $25,277,778Fund first reported on Form ADVFundsFactT••• B••••••••• I• L•••SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Classification history
- Sep 14, 2026Syndicate platform (confirmed, 95%, cls-1)name or self-description says syndicate platform
- Sep 12, 2026Institutional venture firm (confirmed, 95%, cls-1)venture manager, reported GAV $110M across 4 vehicles
Evidence
49 observations from 3 sources
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| Why admitted | vc_exemption,vc_funds_reported | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| SEC exemption claimed | venture_capital_fund_adviser | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| SEC exemption claimed | venture_capital_fund_adviser | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| SEC adviser type | exempt_reporting_adviser | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| SEC adviser type | exempt_reporting_adviser | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| First Form ADV filing | 2020-10-29 | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Adv history loaded | adv-hist-1 | Sep 12, 2026 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Latest Form ADV filing | 2026-03-31 | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Latest Form ADV filing | 2024-03-18 | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| SEC status | ERA - Active | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| SEC status effective | 2020-10-29 | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Venture share of reported funds | 1 | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Business phone | 858-337-8900 | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Business phone | 858-337-8900 | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Contact page url | https://t•••••••••.com/ “contact page linked from the home page” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Description | T••• B••••••••• i•s a full-spectrum healthcare and life sciences venture capital firm based in Southern California. We finance brilliant entrepreneurs with game-changing healthcare technologies to give patients more of life’s most valuable asset: time. Healthcare Venture Capital | Healthcare Investors | Biotech Venture Capital | Biotech Investors | Life Sciences Venture Capital “meta description” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Description | T••• B••••••••• i•s a full-spectrum healthcare and life sciences venture capital firm based in Southern California. We finance brilliant entrepreneurs with game-changing healthcare technologies to give patients more of life’s most valuable asset: time. Healthcare Venture Capital | Healthcare Investors | Biotech Venture Capital | Biotech Investors | Life Sciences Venture Capital “meta description” | Sep 14, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Headquarters | Los Angeles, CA | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Headquarters | Los Angeles, CA | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Office address | 1880 CENTURY PARK E, SUITE 200, Los Angeles, CA, 90067 | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Office address | 1880 CENTURY PARK E, SUITE 200, Los Angeles, CA, 90067 | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Self-described type | syndicate_platform “T••• B••••••••• i•s thrilled to announce its investment in BillionToOne's $125M Series C round, joining co-lead investors Adams Street Partners and Hummingbird Ventures, as well as a syndicate includi” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Self-described type | syndicate_platform “T••• B••••••••• i•s thrilled to announce its investment in BillionToOne's $125M Series C round, joining co-lead investors Adams Street Partners and Hummingbird Ventures, as well as a syndicate includi” | Sep 14, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Legal form | Limited Liability Company | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Legal form | Limited Liability Company | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Portfolio page | https://t•••••••••.com/ “0 entries read” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Portfolio page | https://t•••••••••.com/ “0 entries read” | Sep 14, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Private funds reported | 4 | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Private funds reported | 4 | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Private fund gross assets (reported) | $122M | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Private fund gross assets (reported) | $110M | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Stated sectors | healthcare,biotech,robotics “sector words on the home page” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated sectors | healthcare,biotech,robotics “sector words on the home page” | Sep 14, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated stages | seed “stage words on the home page” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Stated stages | seed “stage words on the home page” | Sep 14, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Team page | https://t•••••••••.com/ “13 name/title pairs read” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Team page | https://t•••••••••.com/ “9 name/title pairs read” | Sep 14, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Venture funds reported | 4 | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Venture funds reported | 4 | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Website | https://t•••••••••.com/ | Mar 31, 2026 | Fact | SEC Form ADV monthly roster (registered + exempt reporting advisers) |
| Website | https://t•••••••••.com/ | Mar 18, 2024 | Fact | SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B) |
| Site title | Healthcare and Biotech Venture Capital | T••• BioVentures “title tag” | Sep 16, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |
| Site title | Healthcare and Biotech Venture Capital | T••• BioVentures “title tag” | Sep 14, 2026 | Fact | Venture organization websites (about, team, portfolio, thesis, news pages) |